Click Here to return To Results

 

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies? Ann Neurol 68:271-274, Tyler,K., 2010 See this aricle in Pubmed Article Abstract No abstract available for this article

Related Tags

(click to filter results - removes previous filter) drug holiday iatrogenic neurologic disorders immunosuppressive agents JC virus monoclonal antibodies multiple sclerosis multiple sclerosis,treatment of natalizumab progressive multifocal leucoencephalopathy risk factors rituximab serologic testing seropositive

Click Here to return To Results